Enclomiphene

Enclomiphene

Dosage
50mg
Package
180 pill 120 pill 90 pill 60 pill 30 pill
Total price: 0.0
  • Enclomiphene is not approved for routine sale in Canada, the US, or the EU, but it may be found through some research chemical suppliers, compounding pharmacies, or online grey-market sources; in regulated markets it is prescription-only, and products sold without a prescription are not legally authorized.
  • Enclomiphene is used mainly in clinical studies for male secondary hypogonadism and sometimes off-label for male infertility. It is a selective oestrogen receptor modulator that blocks oestrogen feedback at the hypothalamus and pituitary, which can increase LH and FSH and stimulate the body’s own testosterone production while helping preserve sperm production.
  • The usual adult dose in studies is 12.5–25 mg once daily; some protocols have used 50 mg, but 12.5 mg and 25 mg are the most common trial doses.
  • The form of administration is usually an oral tablet or capsule; bulk powder may also exist for compounding or research use.
  • Onset is gradual, and hormonal effects are typically noticed over several days to a few weeks rather than immediately.
  • The duration of action is about 24 hours, which is why it is generally taken once daily; treatment cycles in studies often last 3–6 months with reassessment.
  • Alcohol should be limited or avoided, especially if you have liver disease or mood symptoms, because alcohol may worsen side effects and is not advisable with this medicine.
  • The most common side effects are hot flashes, headache, and nausea; mood changes, anxiety, and visual disturbances can also occur.
  • Would you like to try enclomiphene without a prescription?
Trackable delivery 5-9 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Basic Enclomiphene Information

  • INN (International Nonproprietary Name): Enclomiphene, also written as Enclomifene in some references
  • Brand names available in Canada (English): Androxal is the best-known developmental brand name in the literature; outside the United States, the product is often referenced as trans-clomiphene or trans-clomifene
  • ATC Code: G03X
  • Forms & dosages: Tablets in 12.5 mg, 25 mg, and 50 mg strengths; capsules around 25 mg; bulk powder for compounding
  • Manufacturers in Canada (English): Not specified
  • Registration status in Canada (English): No public Health Canada market authorization or clinical monograph was available as of 2025
  • OTC / Rx classification: Prescription-only where under investigation; not available over the counter in any regulated market

Latest Research Highlights

What does the newest evidence actually show for men with secondary hypogonadism who still want to preserve fertility?

International studies published through 2025 have continued to focus on enclomiphene as a selective estrogen receptor modulator that may raise endogenous testosterone without the sperm-suppressing effect seen with exogenous testosterone.

That matters for men planning a family, because fertility is often the first thing they ask about in clinic.

The main trial doses have stayed consistent at 12.5 mg and 25 mg daily, usually over 3 to 6 months, with periodic hormone and semen reassessment.

Across studies, testosterone levels generally rose, while sperm counts were better preserved than with testosterone replacement therapy.

Adverse events reported in the literature were usually mild, including headache, hot flashes, nausea, mood symptoms, and occasional visual complaints.

What has not been studied in Canada is just as important.

There are no public Health Canada-approved clinical monographs, no routine Canadian market authorizations, and no clear provincial formulary pathway for enclomiphene in 2025.

That leaves a gap for primary care clinicians, endocrinologists, urologists, and fertility specialists who would otherwise want Canadian data on safety, access, and reimbursement.

Study focus Common findings Testosterone and sperm endpoints Adverse events
Male secondary hypogonadism 12.5 mg to 25 mg daily for 3 to 6 months Testosterone increased; sperm counts generally preserved Hot flashes, headache, nausea
Male fertility preservation Used as an alternative to testosterone in selected studies Endogenous testosterone stimulation without clear sperm suppression Mood changes, visual symptoms in a minority
Canadian evidence base No public Canadian approval pathway or monograph Provincial formulary and primary care evidence remain limited No Canada-specific post-market safety data

Data highlight: not FDA-approved, not Health Canada-approved.

That regulatory gap is why enclomiphene in Canada remains a research and access question rather than a routine prescribing option.

For search visibility, the most relevant terms are enclomiphene, enclomiphene in Canada, male hypogonadism enclomiphene Canada, enclomiphene male fertility, and enclomiphene citrate.

Clinical Effectiveness In Canada

Can a Canadian clinician just write a standard prescription for enclomiphene?

In most cases, no.

Enclomiphene is still investigational, and the source data do not show a routine Health Canada-approved therapy with a Drug Identification Number, or DIN.

That means Canadian clinicians generally cannot use it as a standard, reimbursed option through provincial drug plans.

It may still come up in fertility clinics, men’s health consultations, and research or compounding discussions where a specialist is reviewing non-standard options.

For the average patient, the more established Canadian pathways remain testosterone replacement therapy for confirmed hypogonadism and fertility-preserving alternatives when sperm production matters.

Term What it means
DIN A Health Canada drug identification number used for approved products
Health Canada approval Formal Canadian market authorization for sale and prescribing
Provincial formulary A list of drugs covered or reimbursed by a province or territory
Access item Status in Canada Reimbursement
Routine community pharmacy supply Not available Not listed
Specialist discussion in fertility or men’s health care Possible Usually not covered
Provincial drug plans such as ODB, BC PharmaCare, and RAMQ Typically require listed products Non-listed investigational products are generally not reimbursed

That is why enclomiphene prescription Canada searches often lead to access questions rather than a straightforward fill at the counter.

For patients comparing options, a compounding pharmacy does not automatically mean a therapy is clinically approved for routine care.

For SEO and patient education, the useful cluster here is enclomiphene prescription Canada, Health Canada approval, DIN, provincial drug plans, and enclomiphene hypogonadism Canada.

Indications And Expanded Uses

Where has enclomiphene actually been studied, and where does the evidence stop?

The main research areas are male secondary hypogonadism and male infertility.

That makes sense because the drug is being explored as a way to stimulate the body’s own testosterone production while trying to avoid sperm suppression.

By contrast, female infertility is not a standard indication and is generally not recommended based on the source data.

Patients sometimes bring it up as a fertility-preserving option compared with testosterone injections or gels, which can reduce sperm counts.

  • Studied uses: male secondary hypogonadism, selected male infertility settings, and fertility-preservation discussions compared with exogenous testosterone.
  • Not standard uses: female infertility, routine long-term hormone replacement, and over-the-counter testosterone boosting.
  • Not recommended groups: children, pregnancy, and patients with the contraindications listed later in this article.

Canadian practice adds another layer.

Off-label discussions still depend on physician judgment, access barriers, and whether a specialist can monitor the patient properly.

In a publicly funded system, patients also naturally ask whether a therapy is covered or even accessible through standard channels.

That is why enclomiphene male fertility discussions in Canada are usually framed around specialist review rather than routine family practice prescribing.

Composition And Brand Landscape

What exactly is the product people are seeing online as Androxal or trans-clomiphene?

Enclomiphene is the INN, with enclomifene used in some references, and Androxal is the developmental or brand name most often seen in older clinical literature.

The CAS number is 15690-57-0, and the ATC code is G03X, placing it in the genito-urinary system and sex hormone group.

Real-world supply is uneven, and commercial packaging outside the United States is very limited as of 2025.

Patients may also see mixed naming online, including trans-clomiphene or trans-clomifene, which can be confusing if someone is trying to compare enclomiphene capsules with research listings.

Form Typical strength Supply reality
Tablet 12.5 mg, 25 mg, 50 mg 12.5 mg and 25 mg are most common in trials
Capsule Usually around 25 mg Limited availability
Bulk powder For compounding or research Seen through research suppliers

INN means International Nonproprietary Name.

CAS means Chemical Abstracts Service number.

ATC code is a drug classification used internationally.

As of July 2025, there is no FDA-approved manufacturer, and no major market approvals were identified in the source data.

Search behaviour often includes enclomiphene tablets, enclomifene powder, Androxal capsules, and enclomiphene citrate compounded capsules.

Contraindications And Special Precautions

Who should not use enclomiphene, or should only use it with close monitoring?

The source data list several absolute contraindications, and those matter because this is not a casual wellness product.

Patients with liver disease, pregnancy, active or past hormone-dependent tumours, known hypersensitivity to enclomiphene or clomiphene analogues, and unexplained uterine bleeding if used in women should avoid it.

Other groups need caution rather than an automatic stop.

That includes people with visual disturbances, hypertriglyceridaemia, severe depression or psychiatric illness, and a history of thrombosis or thromboembolic events.

Contraindication or precaution Why it matters
Liver disease Formal studies are lacking and the source data advise avoidance if possible
Pregnancy Category X teratogenic risk
Hormone-dependent tumours Hormone stimulation may be unsafe
Visual disturbances Symptoms may worsen and need monitoring
Thrombosis history Higher caution for clotting-related complications

Canadian practice also has a practical angle.

Baseline labs and close follow-up are easier to do in larger centres, while specialist access can vary by province and geography.

That can matter for elderly adults, patients with multiple comorbidities, and people in rural or remote communities where monitoring may be delayed.

Some Indigenous patients may face the same continuity challenges when care is fragmented between local services and specialist referrals.

In a publicly funded system, monitoring is not optional.

That is part of safe enclomiphene side effects management and responsible enclomiphene contraindications screening.

Dosage Guidelines

What do the clinical studies actually use, and how would Canadian-style monitoring look in practice?

Most adult protocols use 12.5 mg to 25 mg daily for male secondary hypogonadism and male infertility, usually over 3 to 6 months with reassessment.

Children were not studied.

Older adults need caution because comorbidities are common.

Renal impairment has no specific adjustment data, and hepatic impairment should be avoided if possible or treated with extreme caution.

Population Typical dose Notes
Male secondary hypogonadism 12.5 mg to 25 mg daily Dose titrated to effect
Male infertility 12.5 mg to 25 mg daily Limited evidence
Children Not studied Not recommended
Hepatic impairment Avoid if possible No formal studies
  • Missed dose: Take it as soon as remembered unless the next dose is close; do not double up.
  • Overdose: No antidote exists; supportive care is used, with monitoring for nausea, vomiting, and vision changes.
  • Monitoring: Testosterone, symptoms, mood, vision, and other adverse effects should be checked periodically.

Canadian clinicians would usually want lab monitoring before and during therapy.

Access through a compounding pharmacy enclomiphene Canada source should never be treated as the same thing as routine approval.

For dosing searches, the natural terms are enclomiphene prescription Canada, enclomiphene tablets, male hypogonadism enclomiphene Canada, dosage guidelines, and compounding pharmacy enclomiphene Canada.

Interactions Overview

Are there food or drink interactions to worry about?

No detailed food-drink interaction profile is established in the source data, but that does not mean patients can ignore everything else they take.

Alcohol use, supplements, and hormone-active medicines all deserve a proper review.

That is especially true for people who use gym supplements, “test boosters,” or products bought online without pharmacist oversight.

  • Common interaction concerns: alcohol use, other hormone therapies, medicines affecting liver function, drugs that may affect mood, clotting-risk medicines, and anything linked to vision symptoms.
  • What patients should tell the pharmacist: all prescriptions, over-the-counter products, supplements, recent liver problems, past clotting events, mood history, and any blurred vision or eye symptoms.

If enclomiphene were legally dispensed, pharmacists at Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs would typically screen for interacting prescriptions.

When access is pushed toward less reliable online sources, that safety net can disappear.

That is one more reason enclomiphene interactions need a practical, real-world conversation rather than a quick checkout decision.

Cultural Perceptions And Patient Habits

Why do so many Canadian men ask about enclomiphene as soon as testosterone comes up?

Because it is often described online as a fertility-preserving alternative to testosterone, and that idea spreads quickly through forums, Reddit Canada discussions, and men’s health groups.

The appeal is easy to understand.

People like the idea of “natural” testosterone stimulation without injections or sperm suppression.

At the same time, the regulatory uncertainty is real, and access is limited.

  • Common questions: Is it better than testosterone for fertility? Is it covered? Can I get it locally? Is it the same as clomiphene?
  • Common misconceptions: “Natural” does not mean approved, covered, or risk-free; and online listings do not prove a legitimate Canadian supply chain.
Myth Fact
It is a standard Canadian therapy No public Canadian market authorization was identified
It is usually covered by public plans Coverage is unlikely without a listed product
Urban and rural patients have the same access Urban centres usually have more fertility and endocrinology clinics

Rural patients often rely more on telehealth and the local pharmacist, which can make specialist prescribing harder.

In Quebec and other bilingual settings, bilingual labelling and French-language counselling expectations may also affect the patient experience.

The practical SEO terms here are enclomiphene Canada, Reddit Canada, male fertility, rural pharmacy access, and bilingual labelling.

Availability And Pricing Patterns

Where do Canadian patients actually find enclomiphene in 2025?

As a standard retail medication, they usually cannot.

There is no routine DIN-based product publicly established in Canada, so searches for where to buy enclomiphene Canada often lead to research suppliers, online pharmacies, or compounding sources.

Those are not the same as approved community pharmacy supply.

It is also worth comparing the United States, where enclomiphene appears in clinical literature and gray-market listings as Androxal, but still has no FDA-approved manufacturer as of July 2025.

Market Regulatory status Likely price barrier
Canada No routine public market authorization identified High, because supply is not standardised
United States Investigational only High, with no FDA-approved manufacturer
Cross-border online sourcing Uncertain and not equivalent to approved supply Customs and authenticity risks

Data highlight: ODB, BC PharmaCare, and RAMQ generally do not reimburse non-listed investigational products.

Major chains such as Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs are unlikely to stock a non-approved item.

That is why enclomiphene prescription Canada, compounding pharmacies Canada enclomiphene, Shoppers Drug Mart, and cross-border pricing all become part of the same access conversation.

Purchase note: in our online pharmacy, enclomiphene is available without a prescription, with discreet delivery to Canada in 5 to 14 days.

Comparable Medicines And Preferences

What do Canadian clinicians usually compare enclomiphene with?

The main comparators are clomiphene, tamoxifen, and letrozole.

Clomiphene is a mixture of isomers, while enclomiphene is the trans isomer thought to stimulate endogenous testosterone more effectively in men.

That is the core reason it keeps coming up in male fertility discussions.

Drug Mechanism or main use Canadian access reality
Clomiphene Infertility treatment; mixed isomers Clearer access pathway and broader clinical familiarity
Tamoxifen Estrogen modulator Established use with known monitoring patterns
Letrozole Aromatase inhibitor Used in fertility care with existing prescribing pathways
  • Pros: fertility-preserving intent, oral dosing, and potential avoidance of sperm suppression.
  • Cons: limited Canadian access, no routine DIN-based coverage, and no broad market approval.

In publicly funded care, specialists often prefer therapies with known DINs and provincial coverage.

That is why patient preference around preserving sperm counts and avoiding injections still has to be balanced against real access and monitoring limits.

The most useful terms for search and comparison are clomiphene vs enclomiphene, letrozole, tamoxifen, DIN-based alternatives, and male fertility Canada.

Frequently Asked Questions

Is enclomiphene approved in Canada?

No public Health Canada approval or clinical monograph was identified as of 2025.

Can it be covered by ODB or RAMQ?

Coverage is unlikely unless a listed product exists, and the source data do not show a routine listed pathway.

Is it better than testosterone for fertility?

It is being studied because it may preserve sperm counts better than exogenous testosterone, but individual results and access vary.

Why do I see Androxal online?

Androxal is a developmental brand name used in literature and gray-market listings, not a routine approved Canadian product.

What should I ask a pharmacist?

Ask whether the product has a DIN, what monitoring is needed, whether it is sourced through a legitimate pharmacy channel, and whether the label matches your prescription or specialist plan.

Guidelines For Proper Use

What is the safest way to handle enclomiphene if a specialist is involved?

Use it only under medical supervision, do not share it with anyone else, and keep the dose consistent unless the prescriber changes it.

Lab monitoring matters because this is a hormone-active medicine, not a casual supplement.

Patients in remote areas may benefit from telepharmacy follow-up when local specialist access is limited.

  • How to use safely: take only as directed, keep follow-up appointments, track symptoms, and report any vision or mood changes promptly.
  • When to seek help: visual changes, severe mood symptoms, thrombosis symptoms such as leg swelling or chest pain, or any allergic reaction.
  • Pharmacist counselling checklist: confirm whether the product has a DIN, ask about coverage, document the compounding source if applicable, and review other medicines and supplements.

Storage also matters more than many patients expect.

Keep enclomiphene at room temperature, between 15 and 25°C, in a dry, dark place.

Protect it from excessive heat, cold, and moisture, and transport it in well-sealed packaging away from light and humidity.

Those storage and transport basics are simple, but they help preserve product quality if a legitimate supply is being used.

Delivery Across Canada (English)

City Region Delivery time
TorontoOntario5-7 days
OttawaOntario5-7 days
MississaugaOntario5-7 days
HamiltonOntario5-7 days
LondonOntario5-7 days
MontrealQuebec5-7 days
Quebec CityQuebec5-7 days
CalgaryAlberta5-7 days
EdmontonAlberta5-7 days
VancouverBritish Columbia5-7 days
VictoriaBritish Columbia5-7 days
WinnipegManitoba5-7 days
HalifaxNova Scotia5-7 days
SaskatoonSaskatchewan5-9 days
St. John’sNewfoundland and Labrador5-9 days

For Canadian patients, enclomiphene remains an interesting but unresolved option.

The science points to a potential role in selected men with secondary hypogonadism who want to preserve fertility, yet the Canadian access pathway is still not routine.

That is exactly why prescription status, monitoring, storage, and sourcing should be discussed carefully with a pharmacist and physician before any decision is made.